Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.

• If you are wondering whether Amgen’s recent share price puts it on sale or at a premium, and what that really means for your money, this article focuses squarely on what you are getting for the price you pay.

• Amgen’s stock recently closed at US$355.30, with returns of 1.2% over 7 days, 2.2% over 30 days, 8.4% year to date, 32.2% over 1 year, 60.1% over 3 years, and 61.7% over 5 years. These figures set the scene for a closer look at whether the valuation still stacks up.

• Recent attention on Amgen has centered on its position in large cap pharmaceuticals and biotechnology, particularly as…